Ping Ping is a seasoned biostatistician currently serving as the Director of Biostatistics at Lantheus. They possess extensive experience in statistical analysis, project management, and FDA submissions, having led numerous global clinical trials across various therapeutic areas. Previously, Ping held positions including Lead Biostatistician at the TIMI Study Group and Associate Director of Biostatistics at Travere Therapeutics, where they played a crucial role in achieving FDA approvals. They have recently contributed to the FDA BLA submission for Sickle Cell Disease using CRISPR technology. Ping also obtained a Green Belt certification in Lean Six Sigma in 2024.
This person is not in the org chart
This person is not in any teams
This person is not in any offices